Heterogeneity in retinoblastoma: a tale of molecules and models
Abstract Retinoblastoma, an intraocular pediatric cancer, develops in the embryonic retina following biallelic loss of RB1. However, there is a wide range of genetic and epigenetic changes that can affect RB1 resulting in different clinical outcomes. In addition, other transformations, such as MYCN...
Main Authors: | Sonya Stenfelt, Maria K. E. Blixt, Charlotta All-Ericsson, Finn Hallböök, Henrik Boije |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-11-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-017-0173-2 |
Similar Items
-
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
by: Christiaan M. de Bloeme, et al.
Published: (2024-10-01) -
Morphology and connectivity of retinal horizontal cells in two avian species
by: Anja Günther, et al.
Published: (2025-03-01) -
Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance
by: Tekincan Çağrı Aktaş, et al.
Published: (2023-08-01) -
Dye coupling of horizontal cells in the primate retina
by: Feng Pan, et al.
Published: (2023-11-01) -
Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumors
by: Bo Cheng, et al.
Published: (2024-10-01)